Greenlining Institute Supports Lee-Halpern Petition
By Robert Gnaizda
| 02. 16. 2005
Support For Diversity and Compensation Issues Raised in the Lee-Halpern Petition by the Greenlining Institute
Dear Mr. Klein,
On behalf of Greenlining Institute, we would like to offer to you and the Independent Citizens Oversight Committee our views on two issues in which we have expertise and have been highly involved that have been raised in the Lee-Halpern petition.
First, an essential issue before the Institute is diversity. The issue is of great importance, particularly since the Independent Oversight Committee is admittedly not reflective of California's diversity. This has been compounded by the failure to ensure effective diversity on the first nine hires and apparently in the recommendation of the Interim President of the California Institute for Regenerative Medicine.
Greenlining believes that all regulations should be considered in the context of ensuring full diversity. This includes making diversity a crucial element in evaluating all grants, loans, contracts and hires.
Second, Greenlining has been involved in a wide range of excessive executive compensation cases, including a recent one before the California Public Utilities Commission in the PG&E rate case. Greenlining has also criticized excessive compensation at universities, including U.C.
We believe that there is no correlation...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
